Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.73 |
| ▸ | GAA | P10253 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | CACNA1D | Q01668 | 3/20 | 0.67 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.67 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.67 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.67 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.64 |
| ▸ | CASP1 | P29466 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | XBP1 | P17861 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29173863 | 0.95 | ADORA3 (0.82) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL11860075 | 0.94 | ADORA3 (0.80) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL20610477 | 0.94 | ADORA3 (1.00) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL7817206 | 0.92 | KDM4E (0.88) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL10684386 | 0.91 | ADORA3 (0.75) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL1664685 | 0.89 | ADORA3 (0.71) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL11524972 | 0.89 | ADORA3 (0.71) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL7815344 | 0.88 | ADORA3 (0.74) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL3010331 | 0.87 | ADORA3 (0.70) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL3032293 | 0.87 | KDM4E (0.80) | ADORA3KDM4EALDH1A1TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119819362-A | Photocatalyst for efficiently catalyzing and synthesizing halogenated aromatic hydrocarbon as well as preparation method and application thereof | 中国石油大学(华东) | 2025-04-15 | — | — | CN | claimed |
| CN-119819362-A | Photocatalyst for efficiently catalyzing and synthesizing halogenated aromatic hydrocarbon as well as preparation method and application thereof | 中国石油大学(华东) | 2025-04-15 | — | — | CN | disclosed |
| US-20230382749-A1 | PHOTODRIVEN TRANSFER HYDROGENATION OF N2 TO NH3 | CALIFORNIA INST OF TECHN (US) | 2023-11-30 | — | — | US | disclosed |
| CN-110483563-B | Preparation method and application of novel ionic beta-naphthoic aldehyde Schiff base zirconium complex | 山西医科大学 | 2021-12-28 | — | — | CN | disclosed |
| CN-110683984-A | Method for ultrasonically oxidizing hanster 1, 4-dihydropyridine derivative | 阜阳师范大学 | 2020-01-14 | — | — | CN | disclosed |
| US-20150376224-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-12-31 | — | — | US | disclosed |
| US-20150376224-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-12-31 | — | — | US | disclosed |
| US-20150011749-A1 | USE OF CERTAIN METAL-ACCUMULATING PLANTS FOR THE PERFORMANCE OF ORGANIC CHEMISTRY REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-01-08 | — | — | US | disclosed |
| WO-2014128283-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-08-28 | — | — | WO | disclosed |
| EP-2769765-A1 | Use of compositions obtained by calcing particular metal-accumulating plants for implementing catalytical reactions | Centre National De La Recherche Scientifique (FR) | 2014-08-27 | — | — | EP | disclosed |
| US-4492703-A | HYPOTENSIVE AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1985-01-08 | — | — | US | disclosed |
| US-4304914-A | CARDIOTONIC AGENTS, HYPOTENSIVE AGENTS | USV PHARMACEUTICAL CORPORATION (US) | 1981-12-08 | — | — | US | disclosed |
| US-4248873-A | Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-03 | — | — | US | disclosed |
| US-4188395-A | 1,4-Dihydropyridine derivatives substituted in the 2 position, and their use as medicaments | BAYER AKTIENGESELLSCHAFT (DE) | 1980-02-12 | — | — | US | disclosed |
| US-4179500-A | 1,4-Dihydropyridine-sugar derivatives, and their use as medicaments | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-18 | — | — | US | disclosed |
| US-4177278-A | 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-04 | — | — | US | disclosed |
| US-4166855-A | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ester, and its use as a peripheral vasodilator | BAYER AKTIENGESELLSCHAFT (DE) | 1979-09-04 | — | — | US | disclosed |
| US-4162321-A | Sulphur-containing amino-dihydropyridines, and their use as medicants | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-24 | — | — | US | disclosed |
| US-4146627-A | AMINOALKYLIDEAMINO-1,4-DIHYDROPYRIDINES AND THEIR USE AS MEDICAMENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
| US-3956341-A | 1,3,5-Tricarbo-1,4-dihydropyridines | SMITHKLINE CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011749-A1 | USE OF CERTAIN METAL-ACCUMULATING PLANTS FOR THE PERFORMANCE OF ORGANIC CHEMISTRY REACTIONS | ME1, OSGEP, AGL | ADORA3 2464/4885KDM4E 3624/4885ALDH1A1 912/4885 |
| US-20150376224-A1 | USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS | CACYBP, PPA1, IPMK | ADORA3 4165/4885KDM4E 4437/4885ALDH1A1 3184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.